PliaFX Prime

Optimized Handling. Uncompromised Performance.
Demineralized bone matrices (DBMs) are used in a wide variety of clinical applications for bone repair. An ideal DBM provides both osteoconductive and osteoinductive properties while offering versatile handling. Many commercial DBMs utilize an inert carrier to improve handling, and the proportion of demineralized bone content in the graft varies widely by manufacturer. These carriers do not have a biological function, and they can dilute the osteoinductive potential of the graft. In addition, carriers can negatively affect the release of growth factors and functionality of native cells. PliaFX contains 100% bone and provides optimized handling without compromising the osteoconductive and osteoinductive properties necessary for bone formation. PliaFX hydrates quickly with either blood or saline, providing even more value in convenience and efficiency in the operating room.